Sign in
8-K

Current Report

Aligos Therapeutics, Inc. Filed Acc 0001193125-21-333831

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d437129d8k.htm…